Bcl-2 is an antiapoptotic protein, whose expression unexpectedly correlates with improved overall survival and disease-free survival in BC mainly among luminal A-like breast tumors that have retained ERα signaling (10). This evidence concerns the gene BCL2 and breast cancer.